EcoDrugPlus

Adrenoceptor Beta 1

Ensembl ID : ENSKMAG00000018644
Gene Symbol: ADRB1
3 Cross references
161 Possible Orthologues:

Adrenoceptor Beta 2

Ensembl ID : ENSKMAG00000007924
Gene Symbol: ADRB2
3 Cross references
192 Possible Orthologues:

Aldo-Keto Reductase Family 1 Member B

Ensembl ID : ENSKMAG00000021483
Gene Symbol: AKR1B1
3 Cross references
343 Possible Orthologues:

Aldose Reductase-Like

Ensembl ID : ENSKMAG00000021474
Gene Symbol: LOC108240996
3 Cross references
345 Possible Orthologues:

Alpha Glucosidase

Ensembl ID : ENSKMAG00000019579
Gene Symbol: GAA
3 Cross references
234 Possible Orthologues:

Alpha-1a Adrenergic Receptor-Like

Ensembl ID : ENSKMAG00000003919
Gene Symbol: LOC108236495
3 Cross references
202 Possible Orthologues:

Alpha-2b Adrenergic Receptor-Like

Ensembl ID : ENSKMAG00000008927
Gene Symbol: LOC108230917
3 Cross references
149 Possible Orthologues:

Alpha-2b Adrenergic Receptor-Like

Ensembl ID : ENSKMAG00000002655
Gene Symbol: LOC108233545
3 Cross references
174 Possible Orthologues:

Amine Oxidase Copper Containing 1

Ensembl ID : ENSKMAG00000009658
Gene Symbol: AOC1
3 Cross references
231 Possible Orthologues:

Amyloid Beta Precursor Protein

Ensembl ID : ENSKMAG00000011058
Gene Symbol: APP
4 Cross references
203 Possible Orthologues:

Amyloid-Beta A4 Protein-Like

Ensembl ID : ENSKMAG00000022092
Gene Symbol: LOC108232458
3 Cross references
205 Possible Orthologues:

Androgen Receptor

Ensembl ID : ENSKMAG00000004997
Gene Symbol: AR
3 Cross references
213 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).